FDA-approved medications combined with personalized medical support for sustainable results
Regulates blood sugar and promotes weight loss through dual hormone action.
Learn MoreHelps reduce appetite and calorie intake for effective weight management.
Learn MoreTreatment Details | Mounjaro | Wegovy |
---|---|---|
Active Ingredient | Tirzepatide | Semaglutide |
Expected Weight Loss | Around 20% of body weight | Around 15% of body weight |
Dosing Frequency | Once weekly injection | Once weekly injection |
Eligibility Criteria | BMI ≥30 or ≥27 * | BMI ≥30 or ≥27 * |
Prescription Required | Yes - In-person consultation | Yes - In-person consultation |
* Either BMI above 30 or more than 27 with a cardiovascular disease |